Research Sample bioBank
Small Cell Lung Cancer (SCLC) Clinical Research Samples
Discovery Life Sciences provides the highest quality Small Cell Lung Cancer (SCLC) Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank.
- All Small Cell Lung Cancer (SCLC) Sample Orders are Packaged for Delivery within 24 Hours.
- All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
- Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
- Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations.
|Product ID||Sample||Origin||Matrix||Vial (ml)||Quantity||Price||Age||Gender||Ethnicity||Storage Temp||Sample Date||Test 1||Test Data 1||Sample Detail 1||Test 2||Test Data 2||Test 3||Test Data 3||Product|
|Additional Information 1||Additional Data 1||Additional Information 2||Additional Data 2||Additional Information 3||Additional Data 3||Additional Information 4||Additional Data 4||Additional Information 5||Additional Data 5||Additional Information 6||Additional Data 6||Additional Information 7||Additional Data 7|
|DLS0068139-S||Small Cell Lung Cancer (SCLC)||USA||Serum||1.00||9.00||$150.00||60 Y||F||U/A||<-70C||27-Nov-18||Staging||IV||12-Oct-18||$150.00||Height | Weight||168cm | 82.1kg||Smoking History||Previous, 25-pack-years||Date of Initial Primary Tumor Diagnosis||3/23/2018||Site of Primary Tumor||Prostate||History of Benign Disease prior to Cancer Diagnosis||Diabetes type I||Site of Metastasis||Brain, bilateral adrenal glands, mediastinum, right hilum||Current Medications||Aspirin, ativan, medical marijuana, mirtazapine, novolin, oxycodone, prochlorperazine|
|KHBR19-00057||Small Cell Lung Cancer (SCLC)||USA||Serum||1.50||1.00||$150.00||71 Y||F||White||<-70C||04-Feb-19||Result||Small Cell Lung Cancer||$150.00||Freeze Date||2/28/2019||chemo/immuno therapy|
|DLS0068127-S||Small Cell Lung Cancer (SCLC)||USA||Serum||1.00||9.00||$250.00||51 Y||F||White||<-70C||12-Dec-18||Clinical Diagnosis||Small Cell Lung Cancer||Date of Initial Primary Tumor Diagnosis||2018||Site of Primary Tumor||Mediastinum||$250.00||Site of Metastasis||N/A||History of Benign Disease Prior to Cancer Diagnosis?||Depression, migraines, hypothyroidism||Any Previous Form of Cancer?||No||Most Recent Staging||IIIA||Biomarker Testing Information||N/A||Smoking History||Current; 37-pack-years||Current Medications||Dexamethasone, fluoxetine, levothyroxine, medical marijuana, ondansteron, oxycodone, spiriva respimat, ventolin HFA|
|DLS0068135-S||Small Cell Lung Cancer (SCLC)||USA||Serum||1.00||6.00||$250.00||77 Y||F||White||<-70C||01-Dec-18||Clinical Diagnosis||Small cell lung cancer of central right lung||Date of Initial Primary Tumor Diagnosis||2018||Site of Primary Tumor||Central right lung||$250.00||Site of Metastasis||N/A||History of Benign Disease Prior to Cancer Diagnosis?||COPD, Hypertension, CAD||Any Previous Form of Cancer?||No||Most Recent Staging||pT4N2M0 Stage IIIB||Biomarker Testing Information||N/A||Smoking History||Previous; Years: unknown PPD: unknown||Current Medications||aspirin, cleareyes, dexamethason, flovent, isosorbide mononitrate, metoprolol succinate, olanzapine, oxygen, servent diskus, ventolin|
|DLS0068161-S||Small Cell Lung Cancer (SCLC)||USA||Serum||1.00||9.00||$250.00||62 Y||M||White||<-70C||10-Jan-19||Clinical Diagnosis||Small cell lung cancer||Date of Initial Primary Tumor Diagnosis||2017||Site of Primary Tumor||Upper lobe of left lung||$250.00||Site of Metastasis||Malignant pleural effusion||History of Benign Disease Prior to Cancer Diagnosis?||actinic keratosis, lyme disease, arthralgias in right shoulder, hemorrhoids, increased lipids||Any Previous Form of Cancer?||No||Most Recent Staging||Stage IV T4N3M1a||Biomarker Testing Information||N/A||Smoking History||Previous; Years: 40 PPD: 1||Current Medications||lorazepam, oxycodone, oxycontin, prochlorperazine, zofran|
|DLS0068132-S||Small Cell Lung Cancer (SCLC)||USA||Serum||1.00||6.00||$150.00||57 Y||F||White||<-70C||29-Jan-19||Clinical Diagnosis||Small Cell Lung Cancer||Date of Initial Primary Tumor Diagnosis||2019||Site of Primary Tumor||Right Middle Lobe||$150.00||Site of Metastasis||Lymph nodes||History of Benign Disease Prior to Cancer Diagnosis?||Hypertension, Afib||Any Previous Form of Cancer?||Breast 2009||Most Recent Staging||Stage IIIC T4N3M0||Biomarker Testing Information||N/A||Smoking History||Current; 20-pack-years||Current Medications||Clonidine, prochlorperazine, doxycycline monohydrate, guaifenesin, xarelto, hydroxyzine hydrochloride, metoprolol tartrate, ondansetron|
|DLS0098452||Small Cell Lung Cancer (SCLC)||USA||Serum||1.00||9.00||$150.00||71 Y||M||White||<-70C||28-May-19||Clinical Diagnosis||SCLC of Right upper lobe||Date of Initial Primary Tumor Diagnosis||2019||Site of Primary Tumor||Right upper lobe lung||$150.00||Site of Metastasis||NA||History of Benign Disease Prior to Cancer Diagnosis||facial (cheek) cellulitis, depression, hyperlipidemia, BPH, rosacea, hydrocele, PTSD, hypertensino, insomnia, bilateral cercumen impaction||Any Previous Form of Cancer||Colon Cancer, Kidney Cancer||Staging||Stage IIIA cT3cN1cM0||Biomarker Testing Information||U/A||Smoking History||Previous; Packs Per Day: <1/2 | YRS: 53||Current Medications||amlodipine, aspirin, enteric coated, centrum silver mens, clonazeam, fluoxetine, furosemide, medical marijuana, trazodone, metoprolol tartrate, metronidazole, ondansetron, prochlorperazine, simvastatin, sodium chloride, tamsulsin|
Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.
Please read carefully before purchasing:
Clinical specimens for research use only.
Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.
If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341
These products are supplied without warranty for suitability for specific applications or analytical determinations.
Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.